Covered recipient · General Payments record
GENE A GERMANO
Allopathic & Osteopathic Physicians Psychiatry & Neurology Addiction Medicine
General Payments · PY2018–2024
$1,723.67
- Reported across 54 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $750.04 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $371.53 | 14 |
| Janssen Pharmaceuticals, Inc | $77.92 | 3 |
| Braeburn Inc. | $77.56 | 3 |
| Indivior Inc. | $73.21 | 3 |
| USWM, LLC | $43.72 | 1 |
| ITI, Inc. | $41.43 | 2 |
| Gilead Sciences, Inc. | $25.16 | 1 |
| Alkermes, Inc. | $23.41 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $113.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789761 | CMS |
| ABBVIE INC. | $12.36 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789763 | CMS |
| ABBVIE INC. | $21.26 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789765 | CMS |
| ABBVIE INC. | $15.26 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789767 | CMS |
| ABBVIE INC. | $13.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789769 | CMS |
| ABBVIE INC. | $16.65 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789771 | CMS |
| ABBVIE INC. | $87.82 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789773 | CMS |
| ABBVIE INC. | $9.90 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789775 | CMS |
| ABBVIE INC. | $15.17 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789777 | CMS |
| ABBVIE INC. | $15.62 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789779 | CMS |
| ABBVIE INC. | $16.03 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789781 | CMS |
| ABBVIE INC. | $13.48 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789783 | CMS |
| ABBVIE INC. | $10.25 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789785 | CMS |
| ABBVIE INC. | $11.30 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103789787 | CMS |
| Alkermes, Inc. | $23.41 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120504212 | CMS |
| Braeburn Inc. | $23.46 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601505 | CMS |
| Braeburn Inc. | $27.67 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601507 | CMS |
| Braeburn Inc. | $26.43 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125601509 | CMS |
| Gilead Sciences, Inc. | $25.16 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133835712 | CMS |
| Indivior Inc. | $21.10 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528362 | CMS |
| Indivior Inc. | $28.30 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528364 | CMS |
| Indivior Inc. | $23.81 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144528366 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.62 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143229706 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20.81 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143229710 | CMS |
| Janssen Pharmaceuticals, Inc | $37.98 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078241117 | CMS |
| Janssen Pharmaceuticals, Inc | $22.43 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078240957 | CMS |
| Janssen Pharmaceuticals, Inc | $17.51 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078241247 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.10 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118897292 | CMS |
| USWM, LLC | $43.72 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152823353 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.